Unlock instant, AI-driven research and patent intelligence for your innovation.

Estradiol-4-aminomethyl pyridine conjugate as well as synthetic method and application thereof

A technology of aminomethylpyridine and a synthesis method, applied in the field of estradiol-4-aminomethylpyridine conjugates, can solve the problems such as the inability of continuous medication for patients and the influence of drug treatment effect and the like

Inactive Publication Date: 2014-05-07
GUANGXI NORMAL UNIV
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Many existing anticancer drugs have the disadvantage that while inhibiting the growth of tumor cells, they also seriously inhibit the proliferation of normal cells, resulting in patients who cannot continue to use drugs (Curr Opin Chem Biol, 2009, 13 (3): 256-262 .), each time is often taken at the maximum dose, after a long recovery period, but the recovery of tumor cells and tissues is much faster than normal cells and tissues, which seriously affects the therapeutic effect of the drug (Bioconjug Chem, 2005, 16(4), 803-811; Bioconjug Chem, 2006, 17(5), 1226-1232.)
In recent years, there have been many research reports on estradiol as the lead compound of antitumor drugs (Bioorg Med Chem Lett.2004.14:3829-3833; Steroids.2008.73:1077-1089; Eur J Med Chem.2012.48:385-390), But so far there is no report of 3-hydroxy-17β-[6-(4-pyridine-methylamino)-hexyl-oxygen]-1,3,5(10)-triene-estro

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Estradiol-4-aminomethyl pyridine conjugate as well as synthetic method and application thereof
  • Estradiol-4-aminomethyl pyridine conjugate as well as synthetic method and application thereof
  • Estradiol-4-aminomethyl pyridine conjugate as well as synthetic method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] 1) Synthesis of Compound 2:

[0055] Take estradiol (1.000g, 3.67mmol) in a place with CaCl 2 In the round bottom flask of the drying tube, dissolve with DMF (8.0mL), add benzyl chloride (0.7mL, 6.08mmol) and NaOH (0.265g, 6.63mmol), and react at room temperature for 12h; the reaction solution is suction filtered, and the filter residue is washed with DMF , combined the filtrates, poured the filtrate into ice water, and precipitated a white solid, separated the white solid, and dried to obtain 1.251 g of compound 2 (white solid, yield 94%).

[0056] The above-mentioned compound 2 is detected by proton nuclear magnetic resonance spectrum, and the spectral data are as follows:

[0057] 1H NMR (500MHz, CDCl 3 )δ0.78(s,3H,H-18),1.15-2.32(m,13H,3×CH,5×CH 2 ),2.86(m,2H,H-6),3.73(t,1H,J=8.4Hz,H-17),5.03(s,2H,PhCH 2 0),6.72(d,1H,J=2.2Hz,H-4),6.78(dd,1H,J=2.5,8.5Hz,H-2),7.21(d,1H,J=8.6Hz,H- 1),7.32-7.44(m,5H,Ar-H).

[0058] Therefore, it can be determined that the above-me...

Embodiment 2

[0077] Repeat embodiment 1, difference is, replace step 3) with following step 3a), described step 3a) is as follows:

[0078] 3a) Synthesis of Compound 4:

[0079] Take compound 3 (2.500g, 4.76mmol) and dissolve in CH 3 Add 10%Pd / C (0.05g) to OH (5.0mL), and hydrogenate under normal pressure at room temperature for 12h; 3 After washing with OH, the filtrates were combined, and the obtained filtrate was spin-dried under reduced pressure to obtain 1.346 g of compound 4 (light yellow oil, yield 65%).

[0080] The obtained compound 4 is detected by proton nuclear magnetic resonance spectroscopy, and the obtained spectral data are the same as in Example 1. Therefore, it can be determined that compound 4 is 3-hydroxyl-17β-(6-bromohexyl)oxygen-1,3,5(10)- Triene-Estrogen.

Embodiment 3

[0082] 1) Synthesis of Compound 2:

[0083] Take estradiol (1.000g, 3.67mmol) in a place with CaCl 2 In the round bottom flask of the drying tube, dissolve with pyridine (15.0 mL), add benzyl chloride and NaOH (the molar ratio of estradiol, benzyl chloride and NaOH is 1:3:4), and react at 40°C for 8 h; The reaction solution was suction-filtered, the filter residue was washed with pyridine, the filtrates were combined, and the filtrate was poured into ice water to precipitate a white solid, which was separated and dried to obtain 1.304 g of compound 2 (white solid, yield 98%).

[0084] 2) Synthesis of Compound 3:

[0085] Compound 2 (1.109g, 3.06mmol) was dissolved in THF (5.0mL), NaH was added at 0°C, and after reacting for 90min, 1,6-dibromohexane was added at 0°C (the compound 2 , NaH and 1,6-dibromohexane in a molar ratio of 1:15:3), reacted at room temperature for 15h. The reaction solution was diluted with water, extracted with ethyl acetate, washed with saturated brin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an estradiol-4-aminomethyl pyridine conjugate, namely 3-hydroxyl-17beta-[6-(4-pyridine-methylamino)-hexyl-oxygen]-1,3,5(10)-triene-estra, as well as a synthetic method and application thereof. Through experiments, the applicant discovers that the estradiol-4-aminomethyl pyridine conjugate can excellently inhibit proliferative activity of cell tumor strains such as HepG-2, BGC-823, A549, MCF-7 and PC-3. The structural formula of the estradiol-4-aminomethyl pyridine conjugate is shown in the specification.

Description

technical field [0001] The present invention relates to the field of medical technology, in particular to an estradiol-4-aminomethylpyridine conjugate, namely 3-hydroxyl-17β-[6-(4-pyridine-methylamino)-hexyl-oxygen]-1, 3,5(10)-triene-estro, and its synthesis and application. Background technique [0002] Many existing anticancer drugs have the disadvantage that while inhibiting the growth of tumor cells, they also seriously inhibit the proliferation of normal cells, resulting in patients who cannot continue to use drugs (Curr Opin Chem Biol, 2009, 13 (3): 256-262 .), each time is often taken at the maximum dose, after a long recovery period, but the recovery of tumor cells and tissues is much faster than normal cells and tissues, which seriously affects the therapeutic effect of the drug (Bioconjug Chem, 2005, 16(4), 803-811; Bioconjug Chem, 2006, 17(5), 1226-1232.). Therefore, targeted drugs have received more and more attention and are one of the research hotspots in tum...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07J43/00A61K31/58A61P35/00
Inventor 程克光陈振锋刘观艳邓胜平莫伟彬初相伍姜芸凤
Owner GUANGXI NORMAL UNIV